Browse studies
Find your next paid study
242 recruiting studies matching your filters
Phase 2
A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
The main goal of this phase II study is to evaluate the overall response rate of isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone in relapsed …
Relapsed CancerRefractory Multiple MyelomaMultiple Myeloma
Massachusetts General HospitalNCT05922501
Phase 2
Selinexor for the Treatment of Patients with Intermediate and High-Risk Smoldering Multiple Myeloma
Selinexor is a drug that has been approved in the treatment of patients with symptomatic multiple myeloma. The standard of care for patients with Smoldering Mu…
Smoldering Multiple Myeloma
University of RochesterNCT05597345